Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1 - Top-Institutions - MDSpire

Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1

  • By

  • Longgang Chen

  • Meiling Xu

  • Kai Cheng

  • Lingya Cui

  • Xuefei Mou

  • Changhui Li

  • May 7, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Sarcoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Sarcoma

  • #3

    National NF1 Service
    National NF1 Service

    London, England

    Key Differentiators

    • Neurofibromatosis
    • Oncology

  • #4

    Ludwig-Maximilians-University of Munich
    Ludwig-Maximilians-University of Munich

    Munich, Germany

    Key Differentiators

    • Oncology
    • Pathology

  • #5

    University Hospital Augsburg
    University Hospital Augsburg

    Augsburg, Germany

    Key Differentiators

    • Oncology
    • Pathology

Original Source(s)

Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1

  • by Longgang Chen, Meiling Xu, Kai Cheng, Lingya Cui, Xuefei Mou, Changhui Li

  • May 7, 2026

Related Content

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min
Plasma miR-371a-3p Predicts Recurrence in Stage I Testicular Cancer: Interim Results From the CLIMATE Study

In the management of stage I testicular cancer, a persistent clinical dilemma is the identification of patients who truly need adjuvant treatment after orchiectomy rather than active surveillance alon...

‘Promising’ Signal Only: ctDNA in Early Breast Cancer Not Yet Ready for Clinical Use

Despite compelling prognostic associations across multiple retrospective data sets, no interventional trial has demonstrated that acting on circulating tumor DNA testing results in early breast cancer...